Analysed ZENAS BIOPHARMA INC (ZBIO:NASDAQ) News Sources
Zenas BioPharma Bear Case Overlooks Obexelimab's Commercial Potential, Wedbush Says
17-07-2026
yahoo.com
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18-09-2026
yahoo.com
Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
22-09-2026
yahoo.com
Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026
07-10-2026
yahoo.com
Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease
12-10-2026
yahoo.com
What is the current price of ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?
The current price of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is $24.84.
ZENAS BIOPHARMA INC (ZBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) since the previous trading day is $-0.56.
ZENAS BIOPHARMA INC (ZBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ZENAS BIOPHARMA INC (ZBIO:NASDAQ) since the previous trading day is -2.2047%.
What is the most recent average sentiment score for ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?
The most recent average sentiment score for ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for ZENAS BIOPHARMA INC (ZBIO:NASDAQ)?
The most recent sentiment for ZENAS BIOPHARMA INC (ZBIO:NASDAQ) is .
SEC-8K** Filing Available For ZENAS BIOPHARMA INC (ZBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.